LEVOCETIRIZINE HYDROCHLORIDE: Pharmaceutical manufacturers, suppliers, and packagers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Hetero Labs Ltd Iii	LEVOCETIRIZINE HYDROCHLORIDE	levocetirizine dihydrochloride	SOLUTION;ORAL	210914	ANDA	Camber Pharmaceuticals, Inc.	31722-659-31	1 BOTTLE in 1 CARTON (31722-659-31) / 148 mL in 1 BOTTLE	2019-04-01
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: July 30, 2025

Introduction

Levocetirizine Hydrochloride, a potent antihistaminic agent, is widely used for allergic rhinitis and chronic idiopathic urticaria. Its global demand has led to a robust supply chain, encompassing API manufacturers, formulation specialists, and distribution channels. Ensuring a reliable supplier network is crucial for pharmaceutical companies, healthcare providers, and distributors to maintain consistent quality, cost-efficiency, and regulatory compliance.

This article explores key suppliers of Levocetirizine Hydrochloride, highlighting major API producers, bulk intermediates suppliers, and regional market players. It also discusses the landscape's dynamics, regulatory considerations, and strategic recommendations for stakeholders seeking to optimize their supply chain.

Overview of Levocetirizine Hydrochloride as a Pharmaceutical Ingredient

Levocetirizine Hydrochloride (C_21H_25ClN_2O_2·HCl) is the (R)-enantiomer of cetirizine. Known for its high affinity for peripheral H1 receptors, it offers rapid onset and extended duration of action. As a highly purified API, it is produced through stereoselective synthesis processes, demanding stringent quality control standards to meet pharmacopeial requirements, including USP, EP, and JP specifications.

Major API Suppliers for Levocetirizine Hydrochloride

1. Global Chemical and Pharmaceutical Manufacturers

Several multinational corporations dominate the global Levocetirizine Hydrochloride API market, mainly due to their technological expertise, regulatory track record, and capacity:

Simalab (India): A prominent API manufacturer specializing in antihistamines, Simalab offers high-purity Levocetirizine Hydrochloride compliant with international standards. Their extensive manufacturing capabilities enable bulk orders and reliable supply.
Zhejiang Huahai Pharmaceutical Co., Ltd. (China): A leading Chinese API producer, Huahai Pharmaceuticals supplies Levocetirizine Hydrochloride globally. The company invests heavily in process optimization and quality assurance.
Hetero Labs Limited (India): Hetero is recognized for its comprehensive portfolio of APIs, including Levocetirizine Hydrochloride. They boast a strong R&D pipeline and GMP-compliant facilities.
Mylan (North America/Global): As part of Viatris, Mylan manufactures and distributes Levocetirizine APIs to various regional markets, adhering to strict quality standards.
Biobed Biotech Ltd. (India): A rising player, Biobed Biotech supplies Levocetirizine Hydrochloride with competitive pricing and flexible manufacturing.

2. Specialized API Suppliers and Contract Manufacturers

Formulation and Custom Synthesis Companies: Several smaller firms operate as contract manufacturers, offering customized synthesis and private-label production for pharmaceutical companies seeking to outsource API manufacturing.
Regional Suppliers in Europe and North America: While less dominant, these suppliers often serve niche markets or offer value-added services such as formulation development.

Regional Market Highlights and Notable Suppliers

Asia-Pacific Region

India: Hosts the majority of API manufacturing capacity for Levocetirizine. Companies like Hetero, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries are significant contributors.
China: Noted for cost-competitive production, with Zhejiang Huahai and Zhejiang Hisun Pharmaceutical leading the way, supported by a robust chemical manufacturing sector.

Europe and North America

Europe: Suppliers such as Rottapharm (Italy) provide high-quality APIs, often with stringent GMP compliance geared toward the European market.
North America: Mylan and generic producers primarily import APIs from Asian manufacturers, with some regional production capacity for finished formulations.

Supply Chain Dynamics and Challenges

Regulatory Compliance: Suppliers must meet global standards (USP, EP, JP), with recent emphasis on Good Manufacturing Practice (GMP) adherence to ensure safety and efficacy.
Quality Assurance: Consistency in API quality remains paramount, especially given the stereospecific nature of Levocetirizine.
Market Competition: Price erosions and capacity expansions by Asian manufacturers intensify competition, influencing supplier selection strategies.
Global Disruptions: Supply chain disruptions, including those caused by geopolitical issues, pandemics, and logistics constraints, impact API availability.

Strategic Considerations for Stakeholders

Diversify Suppliers: Avoid reliance on a single manufacturer; establish relationships with multiple API suppliers across regions.
Conduct Due Diligence: Verify GMP compliance, quality certifications, and past performance histories.
Engage in Long-term Contracts: Secure supply continuity through strategic alliances that offer favorable pricing and assured quality.
Monitor Regulatory Changes: Stay abreast of evolving international standards and import/export restrictions to maintain compliance.
Leverage Contract Manufacturing: Consider outsourcing to qualified CDMOs to mitigate capacity constraints or during supply chain disruptions.

Conclusion

The supply landscape for Levocetirizine Hydrochloride is characterized by a mix of established global players and regional manufacturers, predominantly based in Asia. Ensuring a resilient supply chain requires strategic sourcing, rigorous quality control, and proactive management of geopolitical and regulatory risks. Stakeholders should prioritize supplier diversification, continuous quality assessments, and compliance to sustain the availability of this essential medication.

Key Takeaways

Top API suppliers for Levocetirizine Hydrochloride include companies in India, China, and Europe, with major players like Hetero Labs and Zhejiang Huahai leading capacity and quality.
Regional differences influence API sourcing decisions, with Asian manufacturers offering cost-effective options, complemented by high-quality European and North American suppliers.
Regulatory adherence, quality assurance, and supply chain resilience are critical for uninterrupted availability in the global market.
Strategic sourcing, long-term agreements, and supplier diversification underpin supply stability amid market and geopolitical uncertainties.
Staying informed about evolving regulations and building strong supplier relationships can enhance procurement strategies for Levocetirizine Hydrochloride.

FAQs

1. What are the primary regions producing Levocetirizine Hydrochloride?
The leading production regions include India, China, and Europe, with India and China dominating capacity due to cost advantages and established chemical manufacturing sectors.

2. How do I verify the quality of a Levocetirizine API supplier?
Assess GMP certification, regulatory approvals (e.g., FDA, EMA), quality control metrics, and audits of manufacturing facilities. Reviewing supplier dossiers and independent third-party testing reports is also recommended.

3. Are there regulatory considerations when sourcing Levocetirizine Hydrochloride?
Yes. Suppliers must comply with international pharmacopeia standards and meet specific regional registration requirements, such as FDA or EMA approvals, especially for export to regulated markets.

4. Can smaller or regional suppliers reliably provide Levocetirizine API?
While possible, it's essential to verify their quality, GMP compliance, and track record. Larger, well-established suppliers often offer more consistent quality and supply security.

5. What are the risks associated with API supply chain disruptions?
Risks include manufacturing delays, regulatory hurdles, geopolitical tensions, logistical challenges, and quality issues, all impacting drug availability and profitability.

References

[1] "Levocetirizine Hydrochloride - USP/NF," United States Pharmacopeia, 2022.
[2] "API Market Analysis for Antihistamines," GlobalData, 2022.
[3] "Regulatory Guidelines for Antihistamine APIs," EMA, 2023.
[4] "Chinese API Manufacturers – Overview," Chinese Pharmaceutical Industry Report, 2021.
[5] "Global Supply Chain Risks in Pharmaceutical APIs," WHO, 2022.

Suppliers and packagers for LEVOCETIRIZINE HYDROCHLORIDE